Diagnostic Medical Systems S.A. (ALDMS.PA)
EUR 0.68
(-2.57%)
EUR 0.68
(-2.57%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 37.41 Million EUR | 4.74% |
| 2022 | 35.72 Million EUR | 9.61% |
| 2021 | 32.59 Million EUR | 13.37% |
| 2020 | 28.74 Million EUR | 13.0% |
| 2019 | 25.44 Million EUR | 34.2% |
| 2018 | 18.95 Million EUR | 13.3% |
| 2017 | 16.73 Million EUR | -22.93% |
| 2016 | 21.7 Million EUR | 2.64% |
| 2015 | 21.15 Million EUR | 21.64% |
| 2014 | 17.38 Million EUR | 72.23% |
| 2013 | 10.09 Million EUR | 10.05% |
| 2012 | 9.17 Million EUR | -24.59% |
| 2011 | 12.16 Million EUR | 16.24% |
| 2010 | 10.46 Million EUR | 28.45% |
| 2009 | 8.14 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 37.24 Million EUR | 0.0% |
| 2023 Q2 | 32.82 Million EUR | 0.0% |
| 2023 Q1 | 32.82 Million EUR | -8.12% |
| 2023 Q4 | 37.41 Million EUR | 0.0% |
| 2023 Q3 | - EUR | -100.0% |
| 2023 FY | 37.41 Million EUR | 4.74% |
| 2022 Q3 | 35.72 Million EUR | 8.06% |
| 2022 Q2 | 33.05 Million EUR | 0.0% |
| 2022 Q1 | 33.05 Million EUR | 1.43% |
| 2022 FY | 35.72 Million EUR | 9.61% |
| 2022 Q4 | 35.72 Million EUR | 0.0% |
| 2021 Q3 | 32.59 Million EUR | 7.36% |
| 2021 Q2 | 30.35 Million EUR | 0.0% |
| 2021 FY | 32.59 Million EUR | 13.37% |
| 2021 Q4 | 32.59 Million EUR | 0.0% |
| 2021 Q1 | 30.35 Million EUR | 5.6% |
| 2020 Q3 | 28.63 Million EUR | 19.57% |
| 2020 Q1 | 23.94 Million EUR | -5.87% |
| 2020 FY | 28.74 Million EUR | 13.0% |
| 2020 Q2 | 23.94 Million EUR | 0.0% |
| 2020 Q4 | 28.74 Million EUR | 0.4% |
| 2019 FY | 25.44 Million EUR | 34.2% |
| 2019 Q4 | 25.44 Million EUR | 0.0% |
| 2019 Q1 | 21.36 Million EUR | 12.7% |
| 2019 Q2 | 21.36 Million EUR | 0.0% |
| 2019 Q3 | 25.44 Million EUR | 19.08% |
| 2018 Q1 | 16.76 Million EUR | 0.2% |
| 2018 Q2 | 16.76 Million EUR | 0.0% |
| 2018 FY | 18.95 Million EUR | 13.3% |
| 2018 Q4 | 18.95 Million EUR | 0.0% |
| 2018 Q3 | 18.95 Million EUR | 13.07% |
| 2017 FY | 16.73 Million EUR | -22.93% |
| 2017 Q4 | 16.73 Million EUR | 0.0% |
| 2017 Q3 | 16.73 Million EUR | -0.02% |
| 2017 Q2 | 16.73 Million EUR | 0.0% |
| 2017 Q1 | 16.73 Million EUR | -22.91% |
| 2016 Q4 | 21.7 Million EUR | 0.0% |
| 2016 Q2 | 19.89 Million EUR | 0.0% |
| 2016 Q3 | 21.7 Million EUR | 9.1% |
| 2016 Q1 | 19.89 Million EUR | -5.92% |
| 2016 FY | 21.7 Million EUR | 2.64% |
| 2015 Q4 | 21.15 Million EUR | -1.5% |
| 2015 FY | 21.15 Million EUR | 21.64% |
| 2015 Q3 | 21.47 Million EUR | 22.49% |
| 2015 Q2 | 17.52 Million EUR | 0.0% |
| 2015 Q1 | 17.52 Million EUR | 0.81% |
| 2014 FY | 17.38 Million EUR | 72.23% |
| 2014 Q4 | 17.38 Million EUR | 0.0% |
| 2014 Q3 | 17.38 Million EUR | 118.17% |
| 2014 Q2 | 7.97 Million EUR | 0.0% |
| 2014 Q1 | 7.97 Million EUR | -21.06% |
| 2013 Q2 | 7.56 Million EUR | -0.01% |
| 2013 FY | 10.09 Million EUR | 10.05% |
| 2013 Q3 | 10.09 Million EUR | 33.4% |
| 2013 Q4 | 10.09 Million EUR | 0.0% |
| 2013 Q1 | 7.56 Million EUR | -17.5% |
| 2012 FY | 9.17 Million EUR | -24.59% |
| 2012 Q2 | 11.72 Million EUR | 0.0% |
| 2012 Q4 | 9.17 Million EUR | 0.0% |
| 2011 Q2 | 7.25 Million EUR | 0.0% |
| 2011 Q4 | 12.16 Million EUR | 0.0% |
| 2011 FY | 12.16 Million EUR | 16.24% |
| 2010 FY | 10.46 Million EUR | 28.45% |
| 2010 Q4 | 10.46 Million EUR | 0.0% |
| 2010 Q2 | 9.44 Million EUR | 0.0% |
| 2009 Q4 | 8.14 Million EUR | 0.0% |
| 2009 Q2 | 8.28 Million EUR | 0.0% |
| 2009 FY | 8.14 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Affluent Medical SA | 25.15 Million EUR | -48.765% |
| Bluelinea Société Anonyme | 8.86 Million EUR | -322.079% |
| Carmat SA | 96.83 Million EUR | 61.359% |
| Euromedis Groupe | 23.66 Million EUR | -58.093% |
| Eurobio Scientific Société anonyme | 141.15 Million EUR | 73.493% |
| Ikonisys S.A. | 5.11 Million EUR | -630.788% |
| Implanet S.A. | 10.81 Million EUR | -246.092% |
| Median Technologies SA | 46.22 Million EUR | 19.062% |
| SpineGuard SA | 5 Million EUR | -647.811% |
| Theraclion SA | 13.01 Million EUR | -187.449% |
| Euroapi S.A. | 684.7 Million EUR | 94.535% |
| Guerbet SA | 646.97 Million EUR | 94.217% |
| Ion Beam Applications SA | 490.44 Million EUR | 92.371% |
| Koninklijke Philips N.V. | 17.63 Billion EUR | 99.788% |
| Sequana Medical NV | 29.56 Million EUR | -26.55% |